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ABSTRACT
Replication across damaged DNA templates is ac-
companied by transient formation of sister chromatid
junctions (SCJs). Cells lacking Esc2, an adaptor pro-
tein containing no known enzymatic domains, are
defective in the metabolism of these SCJs. However,
how Esc2 is involved in the metabolism of SCJs re-
mains elusive. Here we show interaction between
Esc2 and a structure-specific endonuclease Mus81-
Mms4 (the Mus81 complex), their involvement in the
metabolism of SCJs, and the effects Esc2 has on the
enzymatic activity of the Mus81 complex. We found
that Esc2 specifically interacts with the Mus81 com-
plex via its SUMO-like domains, stimulates enzymatic
activity of the Mus81 complex in vitro, and is involved
in the Mus81 complex-dependent resolution of SCJs
in vivo. Collectively, our data point to the possibil-
ity that the involvement of Esc2 in the metabolism of
SCJs is, in part, via modulation of the activity of the
Mus81 complex.
INTRODUCTION
Replication of damaged DNA leads to replication fork
stalling and accumulation of DNA gaps that may result in
genome instability. Such instability was implicated in in-
creasedmutagenesis, in gross chromosomal rearrangements
(GCR), and is thought to be the driving force for carcino-
genesis (1). DNA damage tolerance (DDT) mechanisms
are crucial to promote replication completion by mediat-
ing fork restart and filling of DNA gaps (2,3). Genetic stud-
ies have delineated two main pathways of DDT: error-free
damage-bypass via recombinationmechanisms and transle-
sional synthesis (TLS)-mediated bypass, also called error-
prone DDT. Error-free DDT involves template switching
(TS) from the damaged parental DNA to the undamaged,
newly synthesized sister chromatid, and proceeds via the
transient formation of sister chromatid junction (SCJ) in-
termediates. In this process, Rad18/Rad5-dependent polyu-
biquitylation of PCNA acts in conjunction with a subset of
homologous recombination factors to mediate SCJ forma-
tion in S-phase (4–8). In addition, later in the cell cycle, an-
other recombination pathway, suppressed early in S phase,
can be used to repair persistent DNA damage (5,8). The
Sgs1 helicase, togetherwith Top3 andRmi1 (henceforth, the
STR-complex; BTR-complex in humans), functions down-
stream of PCNA polyubiquitilation in error-free DDT by
processing the damage-bypass SCJs to yield preferentially
non-crossover recombination intermediates (5,8,9).
Recent work has shown thatMus81-Mms4 nuclease com-
plex (henceforth termed theMus81 complex) serves to back
up the STR complex in resolving SCJs that persist in G2/M
(9,10). However, deletion of either member of the Mus81
complex leads to no discernible accumulation of SCJ in
S-phase, suggesting that the Mus81 complex plays a lim-
ited role in SCJs resolution (9,10). The Mus81 complex
is a structure-specific endonuclease, which in vitro cleaves
a diverse array of complex DNA structures, such as 3′
flap, fork, (nicked) Holliday and D-loop structures, some of
which also arise during error-free DDT (11–15). Based on
the sensitivity of mus81Δ cells to DNA damaging agents
inducing fork stalling (hydroxyurea (HU), campthotecin
(CPT)), it was also proposed that the Mus81 complex
cleaves stalled/collapsed replication forks to promote fork-
restart (16–18). Additionally, activity of the Mus81 com-
plex may promote genome stability during S-phase by re-
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solving collisions between D-loop structures, emanating
from error-free DDT, and replication forks (19). In the later
stages of recombination-mediated DDT, as well as dur-
ing canonical recombination-mediated double strand break
(DSB) repair, the Mus81 complex can resolve recombina-
tion intermediates, forming both cross-over (CO) and non-
crossover (NCO) products (9,20,21). Additionally, human
MUS81 complex promotes replication completion at com-
mon fragile sites after the bulk of DNA replication has been
completed, being required for initiation of mitotic DNA
synthesis (22–24). The activity of theMus81 complex is reg-
ulated by phosphorylation of the Mms4 subunit with var-
ious outcomes, depending on the cell cycle stage and the
kinase involved. During S-phase, the activity of Mus81–
Mms4 is counteracted by DNA damage checkpoint kinases
(9), while in G2/M phase, CDK-dependent phosphoryla-
tion ofMms4 (25,26) promotes HJ resolution by theMus81
complex (9,27). This intricate network of phosphorylation
events play a crucial role in ensuring genome stability by re-
ducing CO formation emanating from the error-free DDT
pathway that accompanies replication.
Establishment of silent chromatin 2 (ESC2) was first
identified as a factor promoting gene silencing (28).
Sequence analyses revealed that Esc2 belongs to a
conserved, eukaryotic-specific SpRad60-ScEsc2-HsNIP45
(RENi) family (29). A feature of the members of the RENi
family lies in their protein structure, which consists of a
tandem of two SUMO-like domains (SLDs) (in case of
Esc2, separated by a highly structured, helical domain)
at their C-terminus, and a polar, unstructured N-terminal
domain. Importantly, Esc2 plays a role in the error-free
DDT pathway as evidenced by esc2Δ cells being sensitive
to the DNA damaging agent methyl-methane sulphonate
(MMS) and accumulating, in amanner reminiscent of STR-
complex mutants, SCJs during replication of damaged tem-
plates (30,31). Our recent work uncovered a two-faceted
role of Esc2 in recombination-mediatedDDT.An early role,
whereby Esc2 promotes recombination-mediated damage-
bypass by limiting Rad51-dismantling by Srs2 (32) and a
later role related to the metabolism of SCJs (30,31). How-
ever, the molecular mechanism by which Esc2 is involved in
the metabolism of SCJs remains unknown.
In this study, we explored the possibility that Esc2 and
the Mus81 complex may cooperate in resolution of recom-
bination intermediates that arise during the error-free DDT
pathway. We first determined that Esc2 preferentially binds
Holliday structures in vitro through its N-terminal domain.
Later, we established that Esc2 directly interacts with the
Mus81 complex. This interaction can be detected through-
out the cell cycle and requires the C-terminal SLD domains
of Esc2. Furthermore, we tested the functional consequence
of the interaction between Esc2 and the Mus81 complex,
and found that Esc2 specifically stimulates the activity of the
Mus81 complex on all tested substrates in vitro and collabo-
rates with the Mus81 complex in the late resolution of SCJs
in mitosis. Our data point to the possibility that one of the
mechanisms bywhich Esc2 is involved in SCJmetabolism in
mitosis is by recognizing the structures and promoting the
activity of the Mus81 complex.
EXPERIMENTAL PROCEDURES
Yeast strains
Yeast strains were constructed as described in (9,33). Yeast
strains used in this study are listed in the Supplementary
Table S1.
Plasmids and DNA substrates
To express and purify Esc2 from E. coli as a fusion with
Gluthation-S-transferase (GST)-tag and a PreScission pro-
tease cleavage site between GST and Esc2, DNA frag-
ment containing ESC2 ORF was cloned into BamHI and
SalI sites of expression vector pGEX6-P1, yielding plas-
mid pGEX6-P1-ESC2. Plasmids for purification of trun-
cated forms of Esc2 (Esc21–199, Esc21–294 and Esc21–374)
were generated by site-directed mutagenesis of the plas-
mid pGEX6-P1-ESC2, introducing a STOP codon at po-
sitions corresponding to amino-acids Y200, E295 and
G375, respectively. To express and purify Esc2 fragments
Esc2193-456, Esc2200-456 and Esc2384-456 in fusion with GST-
tag, DNA fragments containing the corresponding DNA
sequences were cloned intoEcoRI and SalI sites of pGEX6-
P1, yielding plasmids pGEX6-P1-ESC2193–456, pGEX6-P1-
ESC2200–456 and pGEX6-P1-ESC2384–456, respectively. Plas-
mids for purification of Esc2 fragments Esc2193–294 and
Esc2193–374 were generated by site-directed mutagenesis of
pGEX6-P1-ESC2193–456, introducing a STOP codon at po-
sition corresponding to amino-acids E295 and G375, re-
spectively. Primers used to generate various forms of Esc2
protein were purchased from VBC Biotech and are listed in
Supplementary Table S2. The DNA substrates, used in the
study, were prepared as described previously (34).
Purification of Esc2 and its truncations
The ESC2 and its truncated forms were expressed as a GST
fusion proteins in E. coli BL21 RIPL cells (induction: 30◦C,
0.5 mM IPTG, 3 h). All purification steps were performed
at 4◦C. Ten grams of E. coli cell paste were sonicated in 50
ml of lysis buffer C (50 mM Tris–HCl, 10% sucrose (w/v),
protease inhibitors (aprotinin, chymostatin, leupeptin, pep-
statin A, benzamidine, each at 5 g/ml), 10 mM EDTA,
1 mM dithiothreitol (DTT), 0.01% (v/v) Nonidet-P40, and
100mMKCl; pH 7.5). The crude lysate was clarified by cen-
trifugation (100 000 × g for 60 min). The supernatant was
loaded onto a 10-ml Q sepharose column (GE Healthcare)
equilibrated with buffer T (25 mM Tris–Cl, 10% (v/v) glyc-
erol, 5 mM EDTA; pH 7.5) containing 100 mM KCl and
eluted with a 150 ml linear gradient of 100–500 mM KCl
in buffer T. The peak fractions were pooled and batched
for 1 h with 2 ml of glutathione-sepharose 4B beads (GE
Healthcare) equilibrated with buffer T containing 150 mM
KCl. GST-Esc2 was eluted with 6 × 2 ml of 20 mM glu-
tathione in buffer T containing 150 mMKCl. After the elu-
tion, fractions containing GST-Esc2 were pooled and split
into two aliquots. The first aliquot was diluted with 5 ml
of buffer T and loaded onto a 1-ml Mono Q column (GE
Healthcare) equilibrated in buffer T containing 100 mM
KCl. The GST-Esc2 fragments were eluted with a 20-ml
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gradient of 100–600 mM KCl in buffer T. Fractions con-
taining homogenous GST-Esc2 were concentrated in a Vi-
vaspin concentrator (Sartorius Stedim Biotech), and stored
in 10-l aliquots at −80◦C. The second aliquot was incu-
bated with 5–25 g of PreScission protease for 3 h at 4ºC,
to cleave the GST-tag off. Next, the sample was diluted with
5 ml of buffer T and loaded onto a 1-ml Mono Q column
(GE Healthcare) equilibrated in buffer T containing 100
mM KCl. Esc2 were eluted with a 20-ml gradient of 100–
500mMKCl in buffer T. Fractions containing homogenous
Esc2 were concentrated in a Vivaspin concentrator (Sarto-
rius Stedim Biotech) and stored in 10-l aliquots at−80◦C.
GST-Esc2193–294 and GST-Esc2193–374 were expressed and
purified as described above, with the exception that the ini-
tial Q-sepharose chromatographic step was omitted.
Purification of the Mus81 complex
The Mus81 complex was purified as described in (34), with
the exception that E. coliRossetta 2 pLysS was used as host
strain for expression of the complex.
Co-immunoprecipitation
Four hundred ml of exponentially growing cells (1.2 × 107
cells/ml) were suspended in 4 ml of lysis buffer (50 mM
K-HEPES pH 7.5, 140 mM NaCl, Triton X-100, 1 mM
EDTA, 0.1% Na-deoxycholate) supplemented with Pro-
tease inhibitor cocktail (Roche, 1 tablet per 12.5 ml of lysis
buffer), NEM (20 mM), IAA (100 M), phosphatase in-
hibitor cocktail 2 and 3 (5 l each) and disrupted by liq-
uid nitrogen with pestle and mortar as previously described
(30). To the supernatant, 50 l Protein-G Sepharose resin
(50% slurry in lysis buffer) was added and incubated at 4◦C
for 1 h to pre-clear the lysate. Cleared supernatant was then
incubated with 50 l of 50% Protein-G Sepharose resin and
1.5 g of FLAG or PK antibody for 5–6 h at 4◦C. Af-
ter washing the beads three times with 1 ml of lysis buffer,
bound proteins were eluted with SDS-PAGE sample buffer
(35 l). Protein samples were resolved by gradient gels (4-
20%, Bio-Rad) and transferred to Amersham Protran 0.45
nitrocellulosemembrane (G5678144,GE). The experiments
were done twice in independent biological experiments.
In vitro pull-down
Purified GST-Esc2s (3 g) were incubated with the Mus81
complex (3 g) in 30 l of buffer T (20 mM Tris–HCl, 100
mMKCl, 1 mMDTT, 0.5 mM EDTA, and 0.01% Nonidet
P-40; pH 7.5) for 30 min at 4◦C in the presence of GSH-
beads. After washing the beads twice with 100 l of buffer
T, the bound proteins were eluted with 30 l of 5% SDS.
The supernatant (S), wash (W), and SDS eluate (E), 10 l
each, were subjected to SDS-PAGE analysis.
In vivo pull-down
GST or GST-fused proteins (5 g) were immobilised on
30 l of glutathione-sepharose 4B beads. Two hundred ml
of (1.2 × 107 cells/ml) yeast cells were either arrested with
 factor (for G1-phase of the cell cycle; 3 g/ml), or re-
leased into media containing 200 mM HU from G1-arrest
(for S-phase), or arrested with nocodazole (for G2/M; 10
g/ml). Yeast native extract was prepared by lysis in liq-
uid nitrogen (mortar and pestle) in 50 mMHEPES pH 7.4,
140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-
deoxycholate, supplemented with protease inhibitor cock-
tail (Roche) and by pre-clearing by centrifugation. GST
fusion proteins (5 g), immobilised on GTH-beads, were
incubated with 2.5 mg of yeast cell lysate at 4◦C in the
presence of inhibitor cocktail for 2–3 h. The beads were
washed twice with Tris buffer (20 mM Tris–HCl, 150 mM
NaCl, 1mMDTT, 1 mMEDTA, 10% glycerol, 0.1% Triton
X-100; pH 7.5) and twice with Tris buffer containing 350
mM NaCl. The protein complexes, isolated on the beads,
were subjected to a 10% SDS-PAGE and analysed by im-
munoblotting using antibodies recognisingHA and PK epi-
tope, respectively. The proteins were visualised by enhanced
chemiluminescence (ECL), according to the manufacturer’s
instructions (SuperSignal West Dura, Thermo Scientific).
Live cell imaging
Cells were grown shaking in liquid synthetic complete
medium supplemented with 100 g/ml adenine (SC+Ade)
medium at 25◦C to OD600 = 0.2–0.3 and processed for
fluorescence microscopy as described previously (35). For
this study, the following fluorophores were used: yellow flu-
orescent protein (YFP, clone 10C) (36) and turquoise flu-
orescent protein (TFP) (37). Fluorophores were visualized
on a Deltavision Elite microscope (Applied Precision, Inc)
equipped with a 100× objective lens (Olympus U-PLAN S-
APO, NA 1.4), a cooled Evolve 512 EMCCD camera (Pho-
tometrics, Japan), and an Insight solid-state illumination
source (Applied Precision, Inc). Images were acquired using
softWoRx (Applied Precision, Inc) software. Image analy-
sis and fluorescence intensity quantification were done us-
ing Volocity software (PerkinElmer). Images were pseudo-
coloured according to the approximate emissionwavelength
of the fluorophores.
Electrophoretic mobility-shift assay (EMSA)
Purified Esc2 and its truncated forms (16, 31, 63, 125, 250,
500 and 1000 nM) were incubated with the indicated fluo-
rescently labeled substrate (7 nM) at 30◦C in 10 l of buffer
D (40 mM Tris–HCl, 50 mM KCl, 1 mM dithiothreitol, 5
mMMgCl2; pH 7.5) for 10 min. After addition of gel load-
ing buffer (60% glycerol, 10 mM Tris–HCl, 60 mM EDTA,
0.10% Orange G; pH 7.4), the reaction mixtures were re-
solved in a 7.5% native polyacrylamide gels in 0.5xTBE
buffer (45 mM Tris-borate, 1 mM EDTA; pH 7.5) at 4◦C.
The fluorescentDNAspecies were visualized and quantified
using Fuji FLA 9000 imager with theMulti Gauge software
(Fuji).
Nuclease assay
The nuclease assays with the Mus81 complex was per-
formed essentially as described (34). Briefly, reaction mix-
tures containing the Mus81 complex (0.05 nM) and DNA
substrate (7 nM) in 10 l of buffer N (20 mM Tris, 100
mMKCl, 100 g/ml bovine serum albumin, 0.2 mMDTT,
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5% glycerol, and 10 mMMgCl2; pH 8.0) were incubated at
37◦C for 30 min in the absence or presence of Esc2 and its
truncated forms (16, 31, 63, 125, 250, 500 and 1000 nM).
After deproteinization by incubation with 0.1% SDS and
500 g/ml of proteinase K at 37◦C for 5 min, the reactions
were mixed with 1/5 volume of loading buffer and resolved
in a 10% polyacrylamide gel in 1×TBE buffer (90 mMTris-
borate, 2mMEDTA; pH7.5). The fluorescentDNA species
were visualized and quantified as described above.
2D gel analysis and quantification of replication/ recombina-
tion intermediates
G2/M synchronized sgs1 Tc-Esc2-AID (HY5351) and sgs1
Tc-Mms4 (HY1946) cells were treated with MMS for 90
min (MMS), then released in YPD media in two identical
sets of cultures. One set of sgs1 Tc-Esc2-AID cultures was
treated with tetracycline and auxin (Tc+Ax+), one set of
sgs1 Tc-Mms4 cultures was treated with tetracycline (Tc+),
the other set remained untreated during the release. Sam-
ples were taken at the indicated time points for FACS, pro-
tein and 2D gel analysis. Replication intermediates were
visualized using a radioactively labeled probe specific for
ARS305. The quantification of replication intermediates
was performed as described in (9). Mms4 and Esc2 (both
tagged with HA) levels were analyzed by western blot, Pgk1
was used as a loading control. The experiments were per-
formed twice with qualitatively identical results.
RESULTS
Esc2 preferentially binds Holliday junctions
Deletion of ESC2 results in accumulation of unresolved
SCJs upon replication of damaged template (30,31). How-
ever, based on bioinformatic analysis, Esc2 lacks any de-
tectable domain that may be directly accountable for dis-
solution and/or resolution of these structures (29). There-
fore, we first testedwhether Esc2 binds to variousDNA sub-
strates in vitro. We incubated increasing concentrations of
Esc2 with: (i) DNA substrates representing either simple ss-
DNAor dsDNA sequences; (ii) DNA structures that resem-
ble replication intermediates (Y-form, 3′ flap, 5′ flap, and
Fork); or (iii) DNA structures representing SCJs (nicked or
intact Holliday junction structures (nHJ, HJ, respectively)).
Using electrophoretic mobility-shift assay (EMSA) we as-
sessed the DNA binding affinity of Esc2 (Figure 1A), where
∼30% of ssDNA and∼50% of dsDNAwas bound by 1M
Esc2 (Figure 1B). Interestingly, it exhibited 4-fold higher
affinity towards structures representing replication inter-
mediates compared to ss or dsDNA. In particular, ∼50%
of these intermediates were bound at 250 nM (Figure 1A,
B). Even higher affinity was observed towards model SCJs
(nHJ and HJ), binding ∼80% of the substrate at 125 nM
(Figure 1A and B), representing additional 2-fold increase
in affinity compared to the replication intermediates.
Next, we also examined the Esc2 domain responsible
for DNA binding. To this end, we constructed a set of N-
terminally, C-terminally, and internally truncated versions
of Esc2. We first tested their folding by circular dichro-
ism. Spectra of Esc2200-456 and Esc2154-198 fragments were
similar to the spectrum of wild type Esc2 protein, with
prominent -helices. Esc21–199 fragment showed a different
type of spectrum, that resembles a poly-l-proline-II type
(PPII) helix (Supplementary Figure S1B). Next, we deter-
mined affinity of the truncated versions towards HJs. As
shown in Supplementary Figure S2, while Esc2 fragments
Esc21–374, Esc21–294 and Esc21–199 bound HJs with simi-
lar affinities to the wild-type Esc2, the Esc21–151 did not
bind DNA. Furthermore, N-terminally truncated version
of Esc2 (Esc2200–456) also did not bind HJ at concentrations
up to 250 nM. At a very high concentration of Esc2200–456
protein (1 M), it bound 40% of HJ corresponding to a 16-
fold decrease in affinity compared to the wild-type Esc2. To
support the notion, that the DNA binding domain of Esc2
may be located on its N-terminus, we tested an internally
truncated version of Esc2154–198, lacking AA154–198. It
bound only ∼10% and 25% of the nHJ substrate at 250 nM
and 1 M, respectively, representing a 10-fold decrease in
the affinity compared to wild-type protein (Supplementary
Figures S2C and S8C). This data corroborates our earlier
work concerning Esc2 binding to replication fork interme-
diates (32). In summary, Esc2 has very high affinity towards
HJ and nHJ substrates and the region responsible for this
binding is located within the region 154–198 of Esc2, pro-
viding a molecular rationale for its reported in vivo role of
processing SCJs arising via DDT (32).
Esc2 interacts with the Mus81 complex regardless of the cell
cycle stage or phosphorylation status of the Mms4 protein
The structure-specificMus81 nuclease complexwas recently
implicated in the resolution of persistent SCJs arising dur-
ing the error-free DDT specifically in G2/M (9,10). We
asked if Esc2 affects Mus81-dependent resolution of SCJs
and initially tested interaction between Esc2 and theMus81
complex both in vitro and in vivo. Using in vitro pull-down
assay we examined whether purified GST-tagged Esc2 is
able to interact with the Mus81 complex. As shown in Fig-
ure 2A (lanes 5–7), GST-Esc2 efficiently interacted with the
Mus81 complex, indicating direct physical interaction be-
tween Esc2 and the Mus81 complex.
Furthermore, we performed a series of in vivo pull-downs
using cell extracts prepared from cells expressing HA-
tagged Mms4 (Mms4-HA) (9) (Figure 2B). As detected by
western-blot analysis of Mms4-HA using -HA antibodies,
GST-Esc2 (lane 3), in contrast to GST alone (lane 2), was
able to pull-down the Mus81 complex (Figure 2B). More-
over, DNA does not mediate this interaction, as ethidium
bromide (EtBr) did not interfere with the ability of GST-
Esc2 to pull-down the Mus81 complex (Figure 2B, lane 4).
To rule out the possibility that the tag present on Mms4
plays a role in the detected interaction between Esc2 and
theMus81 complex, we conducted the same experiment us-
ing cell extracts prepared from cells expressing C-terminally
PK-tagged MMS4 (9). The same results as for Mms4-HA
were observed (Supplementary Figure S3A), indicating that
the tag present on Mms4 does not affect the interaction.
Next, we asked whether the interaction between Esc2 and
the Mus81 complex is restricted to a particular stage of
the cell cycle. To this end, we synchronized the cells ex-
pressing Mms4-HA at G1, G2/M and S phases of the cell
cycle using -factor, nocodazole and hydroxyurea (HU),
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complex interacts with Esc2 in an in vivo pull-down. Total cell lysates prepared from exponentially growing cells expressing Mms4-HA were incubated
with GST or GST-Esc2. Following wash, the protein complexes were eluted and mixture subjected to 10% SDS-PAGE. Total cell lysates (10% input)
and beads of corresponding pull-downs were analyzed by western blotting using anti-HA antibody. Lane 3 represents GST-Esc2 incubated with total
cell lysate in presence of Ethidium Bromide. The amount of GST and GST-Esc2 protein used is shown by Ponceau staining. (C) The Mus81 complex
interacts with Esc2 in co-immunoprecipitation assay. Protein extracts from cells expressing both Flag-tagged Esc2 and PK-tagged Mms4 were subjected
to immunoprecipitation (IP) using either FLAG or -PK antibody. Empty beads with the antibody conjugated, were used as a control. Protein levels
in the extracts (10% of the input) are shown below the IPs. (D) Esc2 and the Mus81 complex co-localize upon DNA damage. Representative images of
Mus81 and Esc2 colocalization in the nucleus are shown. Yellow arrowheads indicate Mus81-YFP foci, blue arrowheads indicate TFP-Esc2 foci and green
arrowheads indicate colocalization between the two proteins. Scale bar represents 3 m. (E) Quantitative analysis of Mus81 and Esc2 foci. Cells expressing
Mus81-YFP and TFP-Esc2 were untreated or incubated with Zeocin (200 g/ml) for 2 h and focus formation was analyzed. Error bars represent the 95%
confidence intervals. Significant differences (P) observed between untreated and treated cells were determined using one-tailed Fisher’s exact test (n> 150).
(F) The frequency of colocalization betweenMus81 and Esc2 foci was determined for the experiment in panel (E). Error bars represent the 95% confidence
intervals. Significant differences (P) observed between untreated and treated cells were determined using one-tailed Fisher’s exact test.
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respectively, and tested the interaction between GST-Esc2
and the Mus81 complex. As shown in Supplementary Fig-
ure S3B, Esc2 pulled down Mus81 complex from all tested
cell extracts, suggesting that Esc2 interacts with the Mus81
complex throughout the cell cycle. Since the nuclease com-
plex is phosphorylated in G2/M phase by Cdc5-dependent
phosphorylation of Mms4 on various residues, including
the prominent serine 56, and the phosphorylation cor-
relates with improved ability of the Mus81 complex to
cleave HJ-like substrates (9,25,26), we also tested whether
the Esc2-Mms4 interaction is regulated by the phospho-
rylation status of Mms4. Therefore, we performed the in
vivo pull-down with cell extracts expressing phosphomimic-
allele of MMS4 (mms4S56E-HA) (9). GST-Esc2 pulled-
down Mus81-Mms4S56E similarly to the wild-type complex
(Supplementary Figure S3C, compare lanes 5 and 6), indi-
cating that Cdc5-mediated phosphorylation of Mms4 does
not critically influence interaction between Esc2 and the
Mus81 complex.
To further corroborate on Esc2 interaction with the
Mus81 complex in vivo, we tested the interaction in
vivo using co-immunoprecipitation (CoIP) experiments. We
tagged Esc2 andMms4 with Flag- and PK-tag, respectively,
and expressed the genes from their native promoters. In
our experiments, Flag-tagged Esc2 precipitates the Mus81
complex, as evidence by detection of PK-tagged Mms4
subunit (Figure 2C). Moreover, when we performed the
CoIP experiment by precipitating PK-MMS4, we observed
Flag-tagged Esc2 in the eluate fraction (Figure 2C). Fur-
thermore, we monitored Esc2 and Mus81 foci formation
and colocalization in unchallenged cells and cells treated
with zeocin, a drug that generates DNA damage that is
repaired via homology-mediated DNA repair. We tagged
Esc2N-terminally with turquoise fluorescent protein (TFP-
Esc2) and Mus81 with yellow fluorescent protein at the
C-terminus (Mus81-YFP). In untreated cells, only a small
fraction of Mus81 foci colocalized with Esc2 (Figure 2D
and E), which, after treatment with zeocin, resulted in sig-
nificant increase of Esc2 and Mus81 colocalization (67%;
Figure 2E and F). However, deletion of ESC2 does not sig-
nificantly reduce the Mus81 foci (Figure 2E), suggesting
that Esc2 is not required for Mus81 recruitment to sites of
zeocin-generated DNA lesions.
In summary, Esc2 protein interacts directly with the
Mus81 complex both in vitro as well as in vivo, and this inter-
action is largely independent of the cell cycle stage orMms4
phosphorylation status.
Esc2 interacts with the Mus81 complex via its SUMO-like
domains
Identification of the interaction between Esc2 and the
Mus81 complex prompted us to map the Esc2 domain re-
sponsible for the interaction with the Mus81 complex, us-
ing a set of N-terminally or C-terminally truncated versions
of GST-tagged Esc2. These truncations were constructed
to allow us to assess the role of individual SUMO-like do-
mains (SLDs), as well as of the polar N-terminal domain
(Figure 3A) in the interaction. Using pull-downs, we ob-
served that the fragment of GST-Esc2 lacking both SUMO-
like domains (GST-Esc21–199), failed to interact with the
Mus81 complex from a cell extract (Figure 3B). This re-
sult suggested that the SLDs mediate the interaction be-
tween Esc2 and the Mus81 complex. To further test this,
we performed in vitro pull-down experiments with puri-
fied proteins. We found that GST-Esc21–374 (Esc2 fragment
lacking the SLD2 domain), GST-Esc21–294 (Esc2 fragment
lacking the SLD2 and the helical domain separating the
SLDs) interacted the with the Mus81 complex, though to a
lesser extent compared to full-length Esc2 (Figure 3C, com-
pare lanes 14, 15, respectively, with lane 13), indicating that
the SLD2 plays an important role in the interaction. In-
deed, while GST-Esc21–199 (fragment lacking both SLDs)
was not able to interact with the Mus81 complex (Figure
3C, lane 16), the N-terminally truncated GST-Esc2200–456
pulled-down the Mus81 complex efficiently (Figure 3C,
lane 17). Taken together, the results suggest that the SLDs,
but not the N-terminal domain of Esc2, mediate the in-
teraction with the Mus81 complex. In line with this re-
sult, we also detected interaction between Esc2154–198 and
the Mus81 complex (Supplementary Figure S8A). To com-
pare the relative contribution of the individual SLDs, we
tested three additional fragments: GST-Esc2193–294 (SLD1
domain), GST-Esc2193–374 (SLD1 and the helical domain),
and GST-Esc2384-456 (SLD2 domain). As shown in Figure
3C (lanes 18–20), SLD1-containing polypeptides interact
with the Mus81 complex very weakly, in contrast to the
fragment containing SLD2 that showed strong interaction
with the Mus81 complex, comparable to that of the GST-
Esc2200–456 fragment.
The observation that the SLDs of Esc2 mediate the in-
teraction, and their sequence similarity with yeast SUMO
protein (Supplementary Figure S4A and (29)), prompted us
to test direct interaction between ySUMO and the Mus81
complex. As seen in Supplementary Figure S4B, while the
GST-Esc2 and GST-Esc2384–456 (GST-SLD2) interact with
the Mus81 complex, ySUMO has only very weak affinity
towards the Mus81 complex, suggesting there is specificity
of the interaction between SLDs and the Mus81 complex.
In summary, Esc2 interacts with the Mus81 complex via
its SLDs. Furthermore, despite the sequence similarity be-
tween ySUMO and the SLDs, theMus81 complex interacts
specifically with the SLDs of Esc2.
Esc2 specifically stimulates the Mus81 complex activity
The interaction between Esc2 and the Mus81 complex, and
Esc2’s preferential binding to the substrates cleavable by the
Mus81 complex (14,38), prompted us to further test the ef-
fect of Esc2 on the enzymatic activity of the Mus81 com-
plex. To this end, we incubated increasing concentrations of
Esc2 together with the Mus81 complex, which was present
at a concentration to cleave about 10% of the substrate (Fig-
ure 4, lanes 2). Remarkably, Esc2 substantially stimulated
the enzymatic activity of the Mus81 complex on all tested
substrates (Figure 4). The stimulation was observable al-
ready at the lowest concentration of Esc2 tested (15.6 nM)
(Figure 4A, lane 3). At this concentration, the stimulation
was about 2-foldwith themaximum stimulation (6-fold) ob-
served at 250 nM Esc2 (Figure 4A, lane 7). Similar stim-
ulation was also observed for other DNA substrates (Fig-
ure 4B and C). Thus, the presence of Esc2 together with
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the Mus81 complex results in a dramatic stimulation of the
Mus81 complex nuclease activity on various substrates, sug-
gesting that these two proteins may cooperate in the resolu-
tion of SCJs, as well as other substrates of the Mus81 nu-
clease in vivo.
The stimulation of Mus81 activity by Esc2 is specific and re-
quires both the DNA binding and the SLD domains of Esc2
Next, we tested the specificity of Esc2 towards the Mus81
complex. Therefore, we examined whether Rad27, a nucle-
ase acting in Okazaki fragment maturation (39,40), Rad1-
Rad10, another member of XPF/MUS81 family involved
in nucleotide excision repair (41), and human MUS81–
EME1 complex (42,43), are also stimulated by Esc2. Ini-
tially, we tested Esc2 interaction with these proteins us-
ing in vitro pull-down. We found that Esc2 did not in-
teract with Rad27 (Supplementary Figure S5A) and in-
teracted very poorly either with Rad1-Rad10 nuclease or
with hMUS81–EME1 (Supplementary Figure S5B and C,
respectively, compare with Figure 1A). Furthermore, we
tested these enzymes in nuclease assays in the presence or
absence of Esc2. Again, we used concentrations of Rad27,
Rad1–Rad10 and hMUS81-EME1 at which these proteins
cleaved 10–20% of their respective substrates (5′Flap, Y-
form and nHJ, respectively). Addition of Esc2 did not affect
enzymatic activity of either Rad27 or Rad1-Rad10 (Supple-
mentary Figure S5D and S5F), suggesting that the stimula-
tory effect of Esc2 on the Mus81 complex is specific. Fur-
thermore, we tested whether the stimulatory effect of Esc2
on the Mus81 complex is species-specific. Similarly, pres-
ence of Esc2 had no effect on the hMUS81-EME1 activ-
ity (Supplementary Figure S5E and S5F), confirming the
species-specific stimulatory effect of Esc2 on the Mus81
complex. Additionally, we investigated whether Esc2 affects
enzymatic activity of Yen1, a nuclease capable of resolv-
ing HJ that has been involved in metabolism of HJs ema-
nating during HR (25,44,45). Initially, we studied genetic
interactions between ESC2 and YEN1. We tested sensitiv-
ity of single mutants (Δesc2 and Δyen1) and a double mu-
tant Δesc2Δyen1 to MMS. Δesc2 Δyen1 cells were as sen-
sitive as sensitive to MMS as Δesc2 at high concentrations
of MMS (0.015%) and were more sensitive than Δesc2 at
lower concentrations ofMMS (0.01%) (SupplementaryFig-
ure S6). This latter result resembles what has been reported
forΔmus81Δyen1 strains (46). This result further supports
the notion that Esc2 stimulates the nuclease activity of the
Mus81 complex specifically.
In order tomap the Esc2 domain responsible for the stim-
ulation of the Mus81 nuclease activity, we used the above-
described truncated forms of Esc2 (Figure 5A). Incuba-
tion of Esc21-374 and Esc21–294 fragments with the Mus81
complex led to stimulation of the nuclease activity on the
nHJ substrate comparable to that observed for wild-type
Esc2 (Figure 5B). In contrast, Esc2154–198 showed signif-
icant decrease in the stimulation of the nuclease activity,
and Esc21–199 and Esc2200–456 did not stimulate the nuclease
activity at all (Figure 5B, Supplementary Figure S8D and
S8E), suggesting that both DNA binding and the Mus81
complex interaction domains are required for the observed
stimulation. Thus, Esc2 stimulates the Mus81 complex in a
nuclease- and species-specific manner and both the DNA
binding domain and the domain mediating direct physical
interaction between Esc2 and the Mus81 are required for
this stimulation.
Esc2 cooperates with the Mus81 complex in resolution of
SCJs molecules in vivo
Next, we wished to investigate the in vivo relevance of
the observed stimulation of the Mus81 nuclease activity
by Esc2. Therefore, we monitored the kinetics of Mus81-
dependent resolution of SCJs molecules in vivo. We used
an sgs1Δ genetic background to induce the dependence of
their resolution on the Mus81 complex (9). Furthermore,
we used a conditional Tc-ESC2-AID allele to overcome the
synthetic sickness of sgs1Δ esc2Δ cells (Figure 6A) (30).
The kinetics of SCJs resolution were followed for up to 6
h after the release from MMS by 2-D gel electrophoresis.
As seen in the Figure 6B, in cells expressing Esc2, the sig-
nal representing SCJs started to decay already at 2 h post
release from MMS and it eventually disappeared within 6
hours (upper panel). This contrasted to Esc2 depleted cells,
which were delayed in resolving the SCJs, particularly at 3
and 4 h time-point, respectively (Figure 6B; compare up-
per and lower panel and the quantification in Figure 6C).
The observed kinetics were similar to the kinetics exhibited
by cells depleted for the Mus81 complex (Supplementary
Figure S7A, B; and (9)), suggesting that Esc2 may be in-
volved in Mus81-dependent resolution of SCJs. To further
corroborate this finding, we tested genetic interaction of
esc2Δ154–198 allele (an Esc2 variant that binds DNA poorly,
and hence fails to fully stimulate the Mus81-complex in
vitro) with Δsgs1, the main factor responsible for SCJs dis-
solution. As it can be already seen from the tetrad analy-
sis (Supplementary Figure S8B), double esc2Δ154–198Δsgs1
cells show growth defect similar toΔesc2Δsgs1, suggesting
that binding of structured-DNA and full extent of the stim-
ulation of the Mus81 complex is crucial function of Esc2 in
the absence of SGS1. These results suggest that Esc2 plays
a role in the late resolution of SCJs, which is crucially de-
pendent on the Mus81 complex activity, also in vivo.
DISCUSSION
Replication across damaged templates is accompanied by
the formation of SCJs that are toxic for chromosome segre-
gation (5,9,25,47). If left unresolved, they represent a source
of chromosome lesions and crossovers (48–50). The Mus81
complex has been implicated in the resolution of persistent
SCJs in G2/M, in a parallel pathway to the STR complex,
which represents the main mechanism for dissolution of
these DNA structures from S to G2/M (9,10). Similarly to
STRmutants, deletion ofESC2 also results in SCJ accumu-
lation in S phase (30,31), but the functional links between
Esc2 and the other known resolvases (STR and the Mus81
complex) remained elusive.
In the present work, we tested cooperation between Esc2
and the Mus81 complex in the metabolism of intermedi-
ates emanating from the error-free DDT. We determined
that Esc2 binds HJs, an in vitro proxy to the SCJs observed
in vivo (47), with the highest affinity among all tested sub-
strates. Moreover, we mapped the DNA binding domain,
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showing it to be located in the region corresponding to AA
154–198. Importantly, our analysis of secondary structures
in the Esc2 truncations by circular dichroism (CD) further
supported this notion, as the CD spectrum of Esc21–199 re-
sembles poly-l-proline-II type (PPII) helix. PPII helix was
shown that it forms flexible blocks in folded protein struc-
ture and supports protein-protein or protein-nucleic acid in-
teractions (51,52). Hence, the CD studies are in agreement
with the notion that Esc2 protein harbors a DNA-binding
domain. The direct binding of Esc2 to HJs potentially pro-
vides an explanation for the accumulation of SCJs in the
esc2Δ cells. The roles of Esc2 in SCJ metabolism are, how-
ever, broader than the ones of theMus81 complex, as differ-
ently to esc2Δ,mus81Δmutants do not accumulate SCJs in
S phase (9,10,30,31). It is, nonetheless, possible that the late
effect of the Mus81 complex on resolving SCJs depends, in
part, on Esc2. The preferential binding of Esc2 towards HJs
in vitro is reminiscent of Rmi1, a structural component of
the STR complex (53). Later, Rmi1 was shown to stimulate
the decatenation of dHJs by Top3, and this activity required
DNA binding property of Rmi1 (54). Therefore, we specu-
late that Esc2, similarly to Rmi1, can serve as adaptor pro-
tein to promote the activity the Mus81 complex at a subset
of its substrates.
The ability of Esc2 to recognize recombination interme-
diates prompted us to test the interaction between Esc2 and
Mus81 complex both in vivo and in vitro. Our results show
that Esc2 interacts with theMus81 complex throughout the
cell cycle. This suggests that the cell cycle-dependent inter-
play of checkpoint- and CDK-dependent phosphorylation
of Mms4 is not crucial for its interaction with Esc2. This
notion was further substantiated by no observable change
in the Esc2–Mus81 complex interaction when a phospho-
mimic variant of Mms4 (Mms4S56E), resembling CDK-
dependent activation of the Mus81 complex specifically in
G2/M phase, was used (9,25,26). The results support the
view that cell cycle-dependent phosphorylation-mediated
activation ofMus81 andEsc2-mediated interactionwith the
Mus81 complex are not mutually exclusive. Furthermore,
upon zeocin-induced DNA damage, Esc2 and the Mus81
complex co-localize in cells, corroborating our in vitro ex-
periments. However, deletion of Esc2 has no effect on the
ability of the Mus81 complex to form zeocin-induced foci,
suggesting that Esc2 does not play a role in recruitment of
the nuclease complex to damaged site.
Given the sequence and structural similarity between the
Esc2 SUMO-like domains and the ySUMO (Supplemen-
tary Figure S3A and (29)), we studiedwhether ySUMOalso
interacts with the Mus81 complex. Strikingly, we observed
no interaction between the Mus81 complex and ySUMO.
A more detailed sequence comparison of the SLD2 and
ySUMO revealed difference in two phenylalanine residues
located in SLD2 domain responsible for the interaction be-
tween SUMO and SUMO-interacting motif (SIM) (F36,
F37) (55,56), supporting the view that there is specificity
of SLD2 interaction with the Mus81 complex. This result
suggests the existence of mutually exclusive set of interact-
ing partners and different roles for the SLD- and SUMO-
mediated interactions. Since SUMOylation has recently
been proposed to act as a ‘molecular glue’ (57,58), trigger-
ing transient and reversible association of proteins involved
in the same pathway, we speculate that the SLD-mediated
interactions may serve as scaffolds to form transient com-
plexes at various, damage-specific locations and/or sub-
strates. Similar behavior was recently reported for Srs2 and
its interacting partners (59). Furthermore, a recent evidence
suggest that the Drosophila orthologue of Esc2, DmRad60,
promotes genome stability by delocalization of heterochro-
matic DSBs into nuclear periphery, may point in this di-
rection (60). Moreover, the peculiar domain architecture of
Esc2, with SUMO-like sequence being directly embedded in
the protein sequence, would make it immune to deSUMOy-
lation, thus allowing local accumulation of specific proteins
or complexes.
The ability of Esc2 to specifically stimulate the in vitro
Mus81 nuclease activity was further corroborated and
strengthened by the role of Esc2 in promoting Mus81-
dependent resolution of DDT intermediates in vivo. Esc2
may promote activity of theMus81 complex in other in vivo
contexts, including HR-mediated restart of collapsed repli-
cation forks, since Esc2 was shown to maintain the genome
stability in multiple ways (32). The Mus81 complex and
other nucleases involved in DNA replication and/or repair,
including Rad27 and Rad1-Rad10, are stimulated and tar-
geted by a diverse array of repair and replication proteins.
Examples include PCNA and RFC-complex, which stimu-
late Rad27 (61–63) as well as Srs2 andRad54 promoting the
activity of the Mus81 complex (34,64,65). Mechanistically,
these stimulatory factors interact with the particular nucle-
ase, resulting in formation of a complex that cleaves the sub-
strate more efficiently than the nuclease alone, pointing to a
requirement for the specific interaction domain on the stim-
ulating protein. However, the DNA binding of these stimu-
lating proteins is, in general, dispensable for the stimulation.
This is true for the Mus81 complex stimulation by Rad54
(34,64) or Srs2 (65). However, the Esc2-mediated activation
ofMus81 complex differs from the pattern described above,
as it requires both the protein-interaction domain as well as
the DNA binding domain of Esc2 to stimulate the Mus81
complex arguing for a more complex mechanism of stimu-
lation.
Based on our new and previously reported data, a possi-
ble scenario (Figure 7) in which Esc2 and the Mus81 com-
plex may cooperate to promote genome stability. Esc2 may
bind SCJs arising during error-free DDT, and thereby stim-
ulate the Mus81 complex to resolve those structures. There
are several pathways known to be involved in the process-
ing of recombination intermediates. Mechanistically, they
can be divided into two groups: (i) the dissolution mediated
by the STR complex, which consists of convergent branch-
migration coordinated with decatenation (66,67); and (ii)
resolution mediated by, at present, four different nucle-
ase complexes including: the Mus81 complex (9,14,25,26);
Slx1-Slx4 (68); Yen1 (44); and MutL -Exo1 (69,70). In
vivo, besides the STR complex (47), a contribution of the
Mus81-Mms4 complex, likely in the context of the Slx4
scaffold has emerged (9,27). Additionally, the Mus81 com-
plex is required for initiation of mitotic DNA synthesis
upon mild replication stress in humans (24). Notably, single
HJ-like substrates, which arise during recombination and
fork-restart and are not substrates for the STR complex,
need to be resolved before chromosome segregation (19).
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lesion encountered by replication fork
Esc2
Mus81/Mms4
post-replicative ssDNA gaps
(i) S-phase of the cell cycle (ii) G2/M-phase of the cell cycle
dHJ/pseudo HJ resolution
mediated by Esc2-Mus81/Mms4
dHJ/pseudo HJ dissolution
mediated by STR complex
STRSTR
Figure 7. Model of the role of Esc2-Mus81 interaction in promoting genome stability. Hypothetical scenario by which Esc2 and the Mus81 complex
may cooperate to promote genome stability is illustrated. Esc2 and the Mus81 complex may function during the metabolism of sister chromatid junctions
(SCJs). Esc2may specifically bind the 4-way intermediates (Holliday junctions or pseudoHolliday junctions), stimulating the activity of theMus81 complex
towards resolution.
The envisaged action of the Mus81 complex on such single
HJ-like substrates, and its stimulation by Esc2, potentially
explains the synthetic sickness between sgs1Δ mutants and
either esc2Δ and mus81Δ (30). However, considering the
synthetic sickness ofmus81Δ esc2Δ double mutant (30,71),
it is likely that Esc2 and the Mus81 complex act indepen-
dently of each other in specific contexts related to either
particular genomic locations (i.e. silent chromatin for Esc2)
or specific recombination steps (i.e. early stages of the HR-
mediated repair for the Mus81 complex). Future identifi-
cation of conditional and separation-of-function alleles of
MUS81 orESC2mayprovide new and exciting insights into
their mode of action.
Recent works on the metabolism of HJs and HJ-like
structures have yielded a comprehensive picture of the path-
ways involved in their resolution throughout the cell cycle
(reviewed in (72)). However, the molecular mechanism and
regulation of these pathways is still not clear. This work
adds another piece into the complex mosaic of the ways by
which various X-shaped intermediates arising during DNA
metabolism are processed to maintain genomic stability.
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